Copyright
©The Author(s) 2016.
World J Diabetes. Nov 15, 2016; 7(19): 523-533
Published online Nov 15, 2016. doi: 10.4239/wjd.v7.i19.523
Published online Nov 15, 2016. doi: 10.4239/wjd.v7.i19.523
Figure 5 Frequency of β-cell proliferation (A) and apoptosis (B) and ratio of Ki67 to TUNEL positive β-cells (C) were determined by histological analysis.
Values are mean ± SEM (n = 4). Approximately 1000 β-cells were counted per replicate. aP < 0.05 vs diabetic controls.
- Citation: Green AD, Vasu S, McClenaghan NH, Flatt PR. Implanting 1.1B4 human β-cell pseudoislets improves glycaemic control in diabetic severe combined immune deficient mice. World J Diabetes 2016; 7(19): 523-533
- URL: https://www.wjgnet.com/1948-9358/full/v7/i19/523.htm
- DOI: https://dx.doi.org/10.4239/wjd.v7.i19.523